Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)

China · Delayed Price · Currency is CNY

23.41

-1.02 (-4.18%)

At close: Jun 2, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Personal Products	772.01M	547.45M	622.59M	666.56M	984.45M
Personal Products Growth	41.02%	-12.07%	-6.60%	-32.29%	32.49%
Total	772.01M	547.45M	622.59M	666.56M	984.45M
Total Growth	41.02%	-12.07%	-6.60%	-32.29%	32.49%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	252.45M	286.37M	335.58M	276.41M	256.17M
China Growth	-11.84%	-14.67%	21.41%	7.90%	24.38%
Foreign	519.56M	261.08M	287.01M	390.15M	728.27M
Foreign Growth	99.00%	-9.03%	-26.44%	-46.43%	35.61%
Total	772.01M	547.45M	622.59M	666.56M	984.45M
Total Growth	41.02%	-12.07%	-6.60%	-32.29%	32.49%

Source: S&P Global Market Intelligence.